Lipids and Lipid Disorders

Contributing journals to this collection:
JAMA & Archives Journals

Citations 461-470 of 550 total displayed.

Past content

Original Investigations
A Randomized Trial of Improved Weight Loss With a Prepared Meal Plan in Overweight and Obese Patients: Impact on Cardiovascular Risk Reduction

Jill A. Metz; Judith S. Stern; Penny Kris-Etherton; Molly E. Reusser; Cynthia D. Morris; Daniel C. Hatton; Suzanne Oparil; R. Brian Haynes; Lawrence M. Resnick; F. Xavier Pi-Sunyer; Sharon Clark; Leslie Chester; Margaret McMahon; Geoffrey W. Snyder; David A. McCarron
Arch Intern Med 2000; 160: 2150-2158. [Abstract] [Full text] [PDF]  

Original Contributions
Relationship of Baseline Serum Cholesterol Levels in 3 Large Cohorts of Younger Men to Long-term Coronary, Cardiovascular, and All-Cause Mortality and to Longevity

Jeremiah Stamler; Martha L. Daviglus; Daniel B. Garside; Alan R. Dyer; Philip Greenland; James D. Neaton
JAMA 2000; 284: 311-318. [Abstract] [Full text] [PDF]  

Editorials
Early Detection of High Cholesterol Levels in Young Adults

Scott M. Grundy
JAMA 2000; 284: 365-367. [Extract] [Full text] [PDF]  

Original Investigations
Effects of Protease Inhibitors on Hyperglycemia, Hyperlipidemia, and Lipodystrophy: A 5-Year Cohort Study

Sotirios Tsiodras; Christos Mantzoros; Scott Hammer; Matthew Samore
Arch Intern Med 2000; 160: 2050-2056. [Abstract] [Full text] [PDF]  

Original Investigations
Impact of Evidence-Based "Clinical Judgment" on the Number of American Adults Requiring Lipid-Lowering Therapy Based on Updated NHANES III Data

Terry A. Jacobson; Godfrey G. Griffiths; Cristina Varas; Douglas Gause; Jennifer C. Y. Sung; Christie M. Ballantyne
Arch Intern Med 2000; 160: 1361-1369. [Abstract] [Full text] [PDF]  

Neurological Reviews
Role of the Low-density Lipoprotein Receptor–Related Protein in -Amyloid Metabolism and Alzheimer Disease

Bradley T. Hyman; Dudley Strickland; G. William Rebeck
Arch Neurol 2000; 57: 646-650. [Abstract] [Full text] [PDF]  

Original Contributions
Estrogen and Progestin, Lipoprotein(a), and the Risk of Recurrent Coronary Heart Disease Events After Menopause

Michael G. Shlipak; Joel A. Simon; Eric Vittinghoff; Feng Lin; Elizabeth Barrett-Connor; Robert H. Knopp; Robert I. Levy; Stephen B. Hulley
JAMA 2000; 283: 1845-1852. [Abstract] [Full text] [PDF]  

Special Communications
Clinical Goals and Performance Measures for Cholesterol Management in Secondary Prevention of Coronary Heart Disease

Thomas H. Lee; James I. Cleeman; Scott M. Grundy; Clayton Gillett; Richard C. Pasternak; Joshua Seidman; Cary Sennett
JAMA 2000; 283: 94-98. [Abstract] [Full text] [PDF]  

Reviews
Effect of Statins on Risk of Coronary Disease: A Meta-analysis of Randomized Controlled Trials

John C. LaRosa; Jiang He; Suma Vupputuri
JAMA 1999; 282: 2340-2346. [Abstract] [Full text] [PDF]  

Editorials
The Benefits of Lowering Cholesterol in Subjects With Mild Hyperglycemia

Ronald B. Goldberg
Arch Intern Med 1999; 159: 2627-2628. [Extract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55